Table 1 Comparison of baseline characteristics between CKD cases (stage 3 and 4) and ESRD (stage 5) cases.
From: The vitamin D spectrum: insights into 25(OH)D and VDBP in chronic kidney disease and post-transplant
Parameter | Stage 3 and 4 CKD patients (n = 38) Mean ± SD/median (IQR) | ESRD (stage 5) patients (n = 38) Mean ± SD/median (IQR) | p value |
|---|---|---|---|
Age (years) | 53.50 (44.75-61.00) | 35.00(26.75–42.25) | 0.000* |
Gender (M: F) | 32:6 | 29:9 | - |
BMI (kg/m2) | 22.87 ± 4.76 | 23.18 ± 4.09 | 0.753# |
Systolic BP (mmHg) | 120.00(107.75–137.00) | 130.00 (123.75–140.50) | 0.031* |
Diastolic BP (mmHg) | 82.00(72.75–94.25) | 81.00 (75.00–90.00) | 0.954* |
eGFR (ml/min/1.73m2) | 27.50 (23.00–39.00) | 6.00 (6.00–8.00) | 0.000* |
Duration of CKD (months) | 50.00 (32.50-70.25) | 48.00 (14.25-60.00) | 0.237* |
Family history of kidney disease (Yes: No) | 5:33 | 2:36 | - |
Personal history of Smoking (Yes: No) | 19: 19 | 14:24 | - |
Personal history of Alcoholism (Yes: No) | 11:27 | 10:28 | - |
